Latest Health News

Macro Metals Limited has secured $2 million from a strategic placement to Paramount Earthmoving, advanced exploration across multiple Pilbara projects, and entered a second majority Indigenous-owned joint venture, positioning itself for growth in mining services.

Duxton Water Limited reported its strongest quarterly performance since inception, with NAV per share rising 17 cents to $1.71, driven by a $121.3 million sale of water entitlements to the Australian Government and strategic portfolio moves.

Po Valley Energy delivered steady gas output from its Podere Maiar-1 well in Q1 2025 while progressing multi-well drilling applications and a 3D geophysical survey in Italy. The company maintains robust cashflow and a solid financial position as it awaits key regulatory approvals.

Oldfields Holdings Limited reports solid progress in Q3 FY2025, driven by strategic transformation, debt reduction, and a robust sales pipeline supporting a positive outlook for the second half of the year.

HeraMED reports strong Q1 FY25 progress with 4,282 registered users on its HeraCARE platform, a new collaboration with Garmin Health, and advancing commercial deals in the US and Europe. Early clinical data suggests improved maternal outcomes and operational efficiencies.

Bridge SaaS Limited reports a 7% increase in NDIS participant numbers through its majority-owned Brightside, while advancing regional expansion and targeting cash flow positivity by refining operational efficiencies.

Nanoveu Limited has completed its strategic acquisition of EMASS, advancing its foothold in ultra-low-power AI-driven edge computing. The company also strengthened its leadership team and secured additional capital to fuel growth.

AdNeo Limited reports a positive operating cash flow for Q3 FY25, driven by a 60% surge in customer receipts and cost savings exceeding targets. Strategic SaaS contracts and platform upgrades underpin its growth trajectory.

Cardiex reports strong early sales momentum for its CONNEQT Pulse device with approximately 3,000 units sold or contracted since its mid-January launch, supported by innovative app features and operational efficiencies. Despite regulatory delays in the US pharma sector and tariff challenges, the company is positioned for scalable growth and category leadership in preventative cardiovascular care.

Anatara Lifesciences reports mixed results from its Phase II GaRP-IBS trial, missing the primary efficacy target but showing significant improvements in anxiety and patient-reported relief, while advancing its anti-obesity pre-clinical program.

Terragen Holdings has launched its new probiotic products for ruminants, initiated multiple key trials including methane mitigation and crop yield studies, and secured a US patent allowance, positioning itself for global market expansion.

UNITH Ltd reports a 9.3% rise in Q3 FY25 cash receipts driven by its B2C subscription surge and a landmark pharmaceutical contract, alongside strategic platform upgrades and leadership changes.